NYSEAMERICAN:KNW Know Labs (KNW) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free KNW Stock Alerts $0.62 -0.01 (-1.59%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.61▼$0.6650-Day Range N/A52-Week Range$0.23▼$1.48Volume29,808 shsAverage Volume115,355 shsMarket Capitalization$50.38 millionP/E RatioN/ADividend YieldN/APrice Target$1.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Get Know Labs alerts: Email Address Know Labs MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside61.5% Upside$1.00 Price TargetShort InterestHealthy0.67% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.08 out of 5 stars 3.5 Analyst's Opinion Consensus RatingKnow Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageKnow Labs has only been the subject of 1 research reports in the past 90 days.Read more about Know Labs' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.67% of the float of Know Labs has been sold short.Short Interest Ratio / Days to CoverKnow Labs has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Know Labs has recently increased by 2.45%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldKnow Labs does not currently pay a dividend.Dividend GrowthKnow Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for KNW. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Know Labs this week, compared to 0 articles on an average week.MarketBeat Follows4 people have added Know Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Know Labs insiders have not sold or bought any company stock.Percentage Held by Insiders13.70% of the stock of Know Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.96% of the stock of Know Labs is held by institutions.Read more about Know Labs' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Know Labs is -1.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Know Labs is -1.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKnow Labs has a P/B Ratio of 12.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. About Know Labs Stock (NYSEAMERICAN:KNW)Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.Read More KNW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KNW Stock News HeadlinesMay 8, 2024 | businesswire.comKnow Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024May 7, 2024 | msn.comSmart labs for bespoke synthesis of nanomaterials are emergingMay 9, 2024 | American Hartford Gold Group (Ad)Trump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?April 27, 2024 | venturebeat.comYoneda Labs raises $4M from Khosla Ventures to build the ‘OpenAI for chemistry’April 5, 2024 | businesswire.comKnow Labs to Present Clinical Research at the 2024 American Physiology SummitMarch 8, 2024 | stockhouse.comKnow Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyMarch 6, 2024 | finance.yahoo.comKnow Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research StudyMarch 2, 2024 | uk.investing.comKnow Labs secures $12 million investment from LindMay 9, 2024 | American Hartford Gold Group (Ad)Trump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?February 29, 2024 | msn.comKnow Labs secures $12M funding for further execution on clinical research and development initiativesFebruary 29, 2024 | finance.yahoo.comKnow Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development InitiativesFebruary 29, 2024 | businesswire.comKnow Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development InitiativesFebruary 27, 2024 | stockhouse.comKnow Labs Announces the KnowU(TM), its Wearable Non-Invasive Continuous Glucose MonitorFebruary 27, 2024 | businesswire.comKnow Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose MonitorFebruary 15, 2024 | msn.comKnow Labs, Inc. (NYSE:KNW) Q1 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comKnow Labs, Inc. Reports First Quarter FY2024 ResultsFebruary 14, 2024 | businesswire.comKnow Labs, Inc. Reports First Quarter FY2024 ResultsFebruary 7, 2024 | finance.yahoo.comKnow Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024February 5, 2024 | msn.comWestern North Carolina lab begins testing for 'gas station heroin' on the heels of FDA warningJanuary 24, 2024 | msn.comCity of Reedley, Fresno County to receive $260K for illegal lab cleanupJanuary 23, 2024 | finance.yahoo.comKnow Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)December 21, 2023 | finance.yahoo.comKnow Labs, Inc. (NYSE:KNW) Q4 2023 Earnings Call TranscriptDecember 19, 2023 | investorplace.comKNW Stock Earnings: Know Labs Reported Results for Q4 2023December 19, 2023 | msn.comKnow Labs GAAP EPS of -$0.41December 19, 2023 | finance.yahoo.comKnow Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 ResultsDecember 11, 2023 | finance.yahoo.comKnow Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023November 8, 2023 | finance.yahoo.comKnow Labs Expands Board of DirectorsSee More Headlines Receive KNW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/14/2024Today5/09/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A Current SymbolNYSEAMERICAN:KNW CUSIPN/A CIKN/A Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees12Year FoundedN/APrice Target and Rating Average Stock Price Target$1.00 High Stock Price Target$1.00 Low Stock Price Target$1.00 Potential Upside/Downside+61.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,290,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-416.36% Return on Assets-152.02% Debt Debt-to-Equity RatioN/A Current Ratio1.27 Quick Ratio1.27 Sales & Book Value Annual Sales$4.36 million Price / Sales11.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.05 per share Price / Book12.39Miscellaneous Outstanding Shares81,350,000Free Float70,202,000Market Cap$50.38 million OptionableNot Optionable Beta1.54 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Ronald P. Erickson J.D. (Age 80)Founder, CEO, Treasurer & Chairman Comp: $544.97kMr. Peter Joseph ConleyCFO & Senior VP of Intellectual PropertyMs. Jessica English (Age 38)Chief Marketing Officer Dr. James H. Anderson Jr.M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardMr. Steven T. KentChief Product OfficerMr. Leonardo Trautwein (Age 42)Chief Commercial Officer Jordyn HujarChief of StaffMore ExecutivesKey CompetitorsOwletNYSE:OWLTAutoscope TechnologiesNASDAQ:AATCreAlpha TechNASDAQ:AIREAlpha Technology GroupNASDAQ:ATGLuCloudlink GroupNASDAQ:UCLView All CompetitorsInstitutional OwnershipPFG Investments LLCBought 179,977 shares on 4/22/2024Ownership: 0.221%Foguth Wealth Management LLC.Bought 95,790 shares on 4/17/2024Ownership: 0.118%View All Institutional Transactions KNW Stock Analysis - Frequently Asked Questions Should I buy or sell Know Labs stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" KNW shares. View KNW analyst ratings or view top-rated stocks. What is Know Labs' stock price target for 2024? 1 analysts have issued 1 year target prices for Know Labs' stock. Their KNW share price targets range from $1.00 to $1.00. On average, they anticipate the company's stock price to reach $1.00 in the next twelve months. This suggests a possible upside of 61.5% from the stock's current price. View analysts price targets for KNW or view top-rated stocks among Wall Street analysts. How were Know Labs' earnings last quarter? Know Labs, Inc. (NYSEAMERICAN:KNW) posted its quarterly earnings results on Wednesday, February, 14th. The company reported ($0.04) earnings per share for the quarter. Who are Know Labs' major shareholders? Know Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include PFG Investments LLC (0.22%) and Foguth Wealth Management LLC. (0.12%). Insiders that own company stock include Ichiro John Paul Takesako, Jessica English, Leonardo Mouta Trautwein, Ronald P Erickson and William Arthur Owens. View institutional ownership trends. How do I buy shares of Know Labs? Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:KNW) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
